Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder

Nordic Journal of Psychiatry

Volumn 69, Issue 5, 2015, Pages 346-353

  Wysokiński, Adam ^a   Margulska, Aleksandra ^a   Strzelecki, Dominik ^a   Kłoszewska, Iwona ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bipolar disorder; C reactive protein; CRP; Depression; Mania; Schizophrenia

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CAUCASIAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; SEX RATIO; AGED; BLOOD; METABOLISM; YOUNG ADULT;

ADULT; AGED; BIPOLAR DISORDER; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84929915809     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2014.984755     Document Type: Article

References (35)

1. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004 ; 279 : 48487-90
2. Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol 2001 ; 38 : 189-97
3. Kuta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med 1986 ; 164 : 321-6
4. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 2004 ; 44 : 6-11
5. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001 ; 104 : 145-50
6. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yang S, et al. C-reactive protein is elevated in schizophrenia. Schizophr Res 2013 ; 143 : 198-202
7. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Elevated C-reactive protein and cognitive Defi cits in individuals with bipolar disorDer. J Affect Disord 2013 ; 150 : 456-9
8. Liu Y, Al-Sayegh H, Jabrah R, Wang W, Yan F, Zhang J. Association between C-reactive protein and Depression: Modulated by genDer and mediated by body weight. Psychiatry Res 2014 ; 219 : 103-8
9. Yeh ET, Willerson JT. Coming of age of C-reactive protein: Using infl ammation markers in cardiology. Circulation 2003 ; 107 : 370-1
10. Shine B, De Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981 ; 117 : 13-23
11. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Infl ammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorDer: A systematic review of the literature. J Clin Psychiatry 2009 ; 70 : 1078-90
12. Akanji AO, Ohaeri JU, Al-Shammri S, Fatania HR. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Psychiatry Res 2009 ; 169 : 56-61
13. Hamdani N, Doukhan R, Kurtlucan O, Tamouza R, Leboyer M. Immunity, infl ammation, and bipolar disorDer: Diagnostic and therapeutic implications. Curr Psychiatry Rep 2013 ; 15 : 387
14. Karlovic D, Serretti A, Vrkic N, Martinac M, Marcinko D. Serum concentrations of CRP, IL-6, TNF-Alpha and cortisol in major Depressive disorDer with melancholic or atypical features. Psychiatry Res 2012 ; 198 : 74-80
15. Rojas P, Villar M, Gonzalez A, Poblete C, Funez F, Tong A, et al. Increase in C-reactive protein and lipids in adolescents with psychiatric disease. Psychiatry Res 2011 ; 190 : 372-4
16. Suvisaari J, Mantere O. Infl ammation theories in psychotic disorDers: A critical review. Infect Disord Drug Targets 2013 ; 13 : 59-70
17. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, et al. Similar immune profi le in bipolar disorDer and schizophrenia: Selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord 2009 ; 11 : 726-34
18. Vuksan-Cusa B, Sagud M, Jakovljevic M. C-reactive protein and metabolic syndrome in patients with bipolar disorDer compared to patients with schizophrenia. Psychiatr Danub 2010 ; 22 : 275-7
19. Ridker P M. C-reactive protein: A simple test to help predict risk of heart attack and stroke. Circulation 2003 ; 108 : e81-5
20. Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med 2005 ; 352 : 1611-13
21. Maes M, Delange J, Ranjan R, Meltzer HY, DesnyDer R, Cooremans W, et al. Acute phase proteins in schizophrenia, mania and major Depression: Modulation by psychotropic drugs. Psychiatry Res 1997 ; 66 : 1-11
22. Wium-AnDersen MK, Orsted DD, Nielsen SF, NorDestgaard BG. Elevated C-reactive protein levels, psychological distress, and Depression in 73, 131 individuals. JAMA Psychiatry 2013 ; 70 : 176-84
23. Hope S, Melle I, Aukrust P, Agartz I, Lorentzen S, Steen NE, et al. Osteoprotegerin levels in patients with severe mental disorDers. J Psychiatry Neurosci 2010 ; 35 : 304-10
24. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-Analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry 2011 ; 70 : 663-71
25. Wium-AnDersen MK, Orsted DD, NorDestgaard BG. Elevated C-reactive protein, Depression, somatic diseases, and all-cause mortality: A MenDelian randomization study. Biol Psychiatry 2014 ; 76 : 249-57
26. Chaudhry IB, Husain N, Husain MO, Hallak J, Drake R, Kazmi A, et al. Ondansetron and simvastatin adDed to treatment as usual in patients with schizophrenia: Study protocol for a randomized controlled trial. Trials 2013 ; 14 : 101
27. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer s disease. Brain Res 2000 ; 887 : 80-9
28. Harrison NA, Doeller CF, Voon V, Burgess N, Critchley HD. Peripheral infl ammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism. Biol Psychiatry 2014 ; 76 : 585-93
29. Zuckerman L, Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005 ; 39 : 311-23
30. Lepping P, Delieu J, Mellor R, Williams JH, Hudson PR, Hunter-Lavin C. Antipsychotic medication and oxidative cell stress: A systematic review. J Clin Psychiatry 2011 ; 72 : 273-85
31. Klemettila JP, Kampman O, Seppala N, Viikki M, Hamalainen M, Moilanen E, et al. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry Res 2014 ; 218 : 277-83
32. Diaz FJ, Perez-Iglesias R, Mata I, Martinez-Garcia O, Vazquez-Barquero JL, De Leon J, et al. Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naive psychotic sample. Schizophr Res 2010 ; 121 : 207-12
33. Basterzi AD, AyDemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, et al. IL-6 levels Decrease with SSRI treatment in patients with major Depression. Hum Psychopharmacol 2005 ; 20 : 473-6
34. Eller T, Vasar V, Shlik J, Maron E. Pro-infl ammatory cytokines and treatment response to escitalopram in major Depressive disorDer. Prog Neuropsychopharmacol Biol Psychiatry 2008 ; 32 : 445-50
35. Nimmo MA, Leggate M, Viana JL, King JA. The effect of physical activity on mediators of infl ammation. Diabetes Obes Metab 2013 ; 15 Suppl 3 : 51-60